Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of olmesartan medoxomil compared with losartan in patients with hypertension and mild to moderate renal impairment

Next Previous
X
Search
Trial Profile

Efficacy and safety of olmesartan medoxomil compared with losartan in patients with hypertension and mild to moderate renal impairment

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2010

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Losartan
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Europe

    • Most Recent Events

    • 05 May 2008 The primary endpoint has been 'Met' (Change in mean sitting dBP, assessed by conventional blood pressure measurements after 12 weeks of treatment), according to the results published in Journal of Clinical Hypertension.
    • 22 Oct 2007 Status changed from in progress to completed.
    • 29 Oct 2005 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top